Immune checkpoint inhibitors versus chemotherapy as second-line therapy for advanced oesophageal squamous cell carcinoma: a systematic review and economic evaluation.
Shixian LiuLei DouShunPing LiPublished in: Therapeutic advances in gastroenterology (2024)
This study has been registered on the PROSPERO database with the registration number CRD42023495204.